4.7 Article

Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival

Journal

SCIENTIFIC REPORTS
Volume 6, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep28159

Keywords

-

Funding

  1. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development [1IK2BX001587-01]
  2. National Institutes of Health [R01DK104927-01A1]
  3. University of Chicago DRTC [P30DK020595]
  4. National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [F31DK102371]
  5. Northwestern University Program in Endocrinology, Diabetes and Hormone Action [NIH T32 DK007169]
  6. Northwestern University Cellular and Molecular Basis of Disease training grant [NIH T32 GM08061]
  7. American Heart Association Postdoctoral Fellowship [15POST22410016]
  8. American Heart Association pre-doctoral award [15PRE25750015]
  9. Department of Veteran Affairs Tennessee Valley Health Authority [1BX000990-01A1]
  10. Juvenile Diabetes Research Foundation [17-2012-26]
  11. American Diabetes Association [7-10-BETA-03]
  12. Vanderbilt University Training Program in Stem Cell and Regenerative Developmental Biology [T32 HD05702]
  13. NIH [R01 DK060581, UC4 DK104166]
  14. American Diabetes Association
  15. [P30 DK097512]

Ask authors/readers for more resources

The regulation of pancreatic beta cell mass is a critical factor to help maintain normoglycemia during insulin resistance. Nutrient-sensing G protein-coupled receptors (GPCR) contribute to aspects of beta cell function, including regulation of beta cell mass. Nutrients such as free fatty acids (FFAs) contribute to precise regulation of beta cell mass by signaling through cognate GPCRs, and considerable evidence suggests that circulating FFAs promote beta cell expansion by direct and indirect mechanisms. Free Fatty Acid Receptor 2 (FFA2) is a beta cell-expressed GPCR that is activated by short chain fatty acids, particularly acetate. Recent studies of FFA2 suggest that it may act as a regulator of beta cell function. Here, we set out to explore what role FFA2 may play in regulation of beta cell mass. Interestingly, Ffar2(-/-) mice exhibit diminished beta cell mass at birth and throughout adulthood, and increased beta cell death at adolescent time points, suggesting a role for FFA2 in establishment and maintenance of beta cell mass. Additionally, activation of FFA2 with G alpha(q/11)-biased agonists substantially increased beta cell proliferation in in vitro and ex vivo proliferation assays. Collectively, these data suggest that FFA2 may be a novel therapeutic target to stimulate beta cell growth and proliferation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available